RAC 0.27% $1.82 race oncology ltd

Ann: Impressive Bisantrene Phase 2 AML Clinical Results

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.